Visión generalGráficoNoticiasTraderScreen

Goldman Sachs Aktienanleihe RWE 2.../  DE000GG1DZN7  /

EUWAX
13/05/2024  10:46:45 Diferencia+0.41 Bid22:00:40 Ask22:00:40 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
82.21EUR +0.50% -
Volumen de oferta: -		 -
Tamaño/ Volumen/ Formato de Ask: -		 RWE AG INH O.N. 49.00 - 20/11/2024 Call
TeleTrader 5:24 Russia downs 'several air targets' over Belgorod
GlobeNewswire 5:01 MKS Instruments Announces Pricing of Upsized Private Offering of $1.2 Billion of 1.25% Convertible S...
GlobeNewswire 5:00 WASD Studios announces its custom WEB3 Gamefi initiative
TeleTrader 4:46 Blinken arrives in Kiev to show US support
TeleTrader 4:30 Walmart to reportedly cut jobs, move staff to central hubs
GlobeNewswire 4:10 Kilmer Sports Ventures Enters into Exclusive Negotiations to Acquire French Professional Football Cl...
TeleTrader 4:03 Asia-Pacific mixed after Japanese data
Newsfile Corp 3:57 Design Firm MARGARITA BRAVA Releases Interview
GlobeNewswire 3:50 Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 3:00 Infinera to Announce Preliminary Fiscal First Quarter 2024 Financial Results on May 14, 2024
TeleTrader 3:00 US allegedly thinks Israel has enough troops for Rafah incursion
GlobeNewswire 3:00 GLOBAL LIFE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Bee...
GlobeNewswire 2:29 AKRO INVESTOR ALERT: Edelson Lechtzin LLP Urges Akero Therapeutics, Inc. (NASDAQ: AKRO) Shareholders...
TeleTrader 2:25 US destroys two Houthi drones, one anti-ship missile
GlobeNewswire 2:06 MBUU INVESTOR ALERT: Edelson Lechtzin LLP Urges Malibu Boats, Inc. (NASDAQ: MBUU) Shareholders With ...
GlobeNewswire 2:02 GCC Announces Dividend Payment
GlobeNewswire 2:00 ROSEN, A LEADING LAW FIRM, Encourages Rivian Automotive, Inc. Investors With Losses in Excess of $10...
GlobeNewswire 2:00 HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- an...
GlobeNewswire 2:00 HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatme...
GlobeNewswire 1:55 StakingFarm Gains Traction Amid Ark Invest’s Removal of Staking from Ethereum ETF Proposal
TeleTrader 1:50 Japan's producer prices rise 0.9% in April
TeleTrader 1:46 Hezbollah claims responsibility for 7 attacks on Israel
GlobeNewswire 1:44 Ocugen, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; June 10, 2024 de...
GlobeNewswire 1:41 bluebird bio, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 20...
GlobeNewswire 1:30 SHOALS TECHNOLOGIES GROUP, INC. investors: Please contact the Portnoy Law Firm to recover your losse...